NRXP
NRX Pharmaceuticals Inc
3.00$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | +0.0% | -100.0% | – | +306.2% | +8.6% | +3.1% | – | |
| – | – | +41.3% | -19.0% | +357.2% | – | – | – | – | – | – | – | – | – | +8.7% | -34.0% | -38.1% | +153.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% | +100.0% | -50.0% | +100.0% | -100.0% | – | +268.1% | +56.7% | +5.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | +356.7% | -42.7% | -5.1% | – | |
| – | – | – | – | – | – | – | – | – | -25.2% | +229,969.0% | +211.5% | – | – | +60.2% | +34.7% | +2.2% | -14.5% | -46.1% | +39.6% | +7.9% | -18.1% | +6.1% | -14.4% | -23.5% | -31.0% | +60.4% | -78.2% | +69.6% | -22.4% | +22.8% | +44.8% | -61.0% | +134.6% | +61.7% | – | |
| – | – | +41.3% | -19.0% | +46.2% | -49.3% | – | – | – | -99.6% | +85,295.3% | +614.0% | -88.3% | +379.9% | +493.0% | +11.0% | +236.8% | -78.0% | -35.0% | -24.5% | +8.4% | +6.5% | -29.7% | -38.6% | -24.9% | +127.0% | -0.1% | -43.2% | +7.8% | +13.3% | -6.8% | +2.4% | +62.7% | -16.5% | +24.4% | – | |
| – | +43.1% | +41.3% | -19.0% | +46.2% | -49.3% | +7.7% | +4.3% | +4.2% | -37.5% | +1,506.1% | +322.0% | – | – | +241.6% | +17.4% | +163.6% | -70.4% | -38.9% | -4.8% | +8.2% | -4.6% | -15.9% | -26.8% | -24.1% | +36.1% | +17.5% | -57.2% | +20.3% | +5.9% | -3.0% | +13.2% | +20.1% | -1.0% | +34.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +394.2% | – | – | +2.1% | +5.1% | -56.3% | +28.0% | +87,166.7% | -97.8% | -94.8% | +53,366.7% | -100.0% | – | +100.0% | +187.5% | +269.1% | -100.0% | – | – | – | – | – | -65.3% | +3.0% | – | |
| – | – | -88.0% | +2,588.5% | -104.1% | – | -1.4% | -65.4% | -124.9% | – | -70.4% | -5,146.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -497.2% | – | – | |
| – | – | +117.4% | +291.0% | -190.7% | – | +28.3% | -61.3% | -124.9% | – | -109.3% | – | – | – | – | -100.0% | -99,764.7% | – | – | – | – | – | -115.6% | – | -3,585.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -142.6% | – | +3.8% | +545.1% | -6.4% | -66.4% | -124.9% | – | -62.6% | -5,146.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -497.2% | – | – | |
| – | – | -88.0% | +2,588.5% | -610.5% | – | -1.4% | -65.4% | -124.9% | – | -69.7% | -5,011.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -191.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.